IBDEI0JH ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,9534,2)
 ;;=^33586
 ;;^UTILITY(U,$J,358.3,9535,0)
 ;;=272.0^^67^663^22
 ;;^UTILITY(U,$J,358.3,9535,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9535,1,4,0)
 ;;=4^272.0
 ;;^UTILITY(U,$J,358.3,9535,1,5,0)
 ;;=5^Hypercholesterolemia, Pure
 ;;^UTILITY(U,$J,358.3,9535,2)
 ;;=Hypercholesterolemia, Pure^59973
 ;;^UTILITY(U,$J,358.3,9536,0)
 ;;=272.1^^67^663^28
 ;;^UTILITY(U,$J,358.3,9536,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9536,1,4,0)
 ;;=4^272.1
 ;;^UTILITY(U,$J,358.3,9536,1,5,0)
 ;;=5^Hypertriglyceridemia, Pure
 ;;^UTILITY(U,$J,358.3,9536,2)
 ;;=Hypertriglyceridemia, Pure^101303
 ;;^UTILITY(U,$J,358.3,9537,0)
 ;;=272.2^^67^663^24
 ;;^UTILITY(U,$J,358.3,9537,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9537,1,4,0)
 ;;=4^272.2
 ;;^UTILITY(U,$J,358.3,9537,1,5,0)
 ;;=5^Hyperlipidemia, Mixed
 ;;^UTILITY(U,$J,358.3,9537,2)
 ;;=^78424
 ;;^UTILITY(U,$J,358.3,9538,0)
 ;;=275.42^^67^663^21
 ;;^UTILITY(U,$J,358.3,9538,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9538,1,4,0)
 ;;=4^275.42
 ;;^UTILITY(U,$J,358.3,9538,1,5,0)
 ;;=5^Hypercalcemia
 ;;^UTILITY(U,$J,358.3,9538,2)
 ;;=^59932
 ;;^UTILITY(U,$J,358.3,9539,0)
 ;;=275.41^^67^663^29
 ;;^UTILITY(U,$J,358.3,9539,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9539,1,4,0)
 ;;=4^275.41
 ;;^UTILITY(U,$J,358.3,9539,1,5,0)
 ;;=5^Hypocalcemia
 ;;^UTILITY(U,$J,358.3,9539,2)
 ;;=^60542
 ;;^UTILITY(U,$J,358.3,9540,0)
 ;;=276.7^^67^663^23
 ;;^UTILITY(U,$J,358.3,9540,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9540,1,4,0)
 ;;=4^276.7
 ;;^UTILITY(U,$J,358.3,9540,1,5,0)
 ;;=5^Hyperkalemia
 ;;^UTILITY(U,$J,358.3,9540,2)
 ;;=^60042
 ;;^UTILITY(U,$J,358.3,9541,0)
 ;;=275.2^^67^663^19
 ;;^UTILITY(U,$J,358.3,9541,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9541,1,4,0)
 ;;=4^275.2
 ;;^UTILITY(U,$J,358.3,9541,1,5,0)
 ;;=5^Hyper Or Hypomagnesemia
 ;;^UTILITY(U,$J,358.3,9541,2)
 ;;=^35626
 ;;^UTILITY(U,$J,358.3,9542,0)
 ;;=276.0^^67^663^25
 ;;^UTILITY(U,$J,358.3,9542,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9542,1,4,0)
 ;;=4^276.0
 ;;^UTILITY(U,$J,358.3,9542,1,5,0)
 ;;=5^Hypernatremia
 ;;^UTILITY(U,$J,358.3,9542,2)
 ;;=^60144
 ;;^UTILITY(U,$J,358.3,9543,0)
 ;;=276.1^^67^663^32
 ;;^UTILITY(U,$J,358.3,9543,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9543,1,4,0)
 ;;=4^276.1
 ;;^UTILITY(U,$J,358.3,9543,1,5,0)
 ;;=5^Hyponatremia
 ;;^UTILITY(U,$J,358.3,9543,2)
 ;;=Hyponatremia^60722
 ;;^UTILITY(U,$J,358.3,9544,0)
 ;;=275.3^^67^663^20
 ;;^UTILITY(U,$J,358.3,9544,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9544,1,4,0)
 ;;=4^275.3
 ;;^UTILITY(U,$J,358.3,9544,1,5,0)
 ;;=5^Hyper Or Hypophosphatemia
 ;;^UTILITY(U,$J,358.3,9544,2)
 ;;=^93796
 ;;^UTILITY(U,$J,358.3,9545,0)
 ;;=240.0^^67^663^14
 ;;^UTILITY(U,$J,358.3,9545,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9545,1,4,0)
 ;;=4^240.0
 ;;^UTILITY(U,$J,358.3,9545,1,5,0)
 ;;=5^Goiter, Simple
 ;;^UTILITY(U,$J,358.3,9545,2)
 ;;=^259806
 ;;^UTILITY(U,$J,358.3,9546,0)
 ;;=241.1^^67^663^13
 ;;^UTILITY(U,$J,358.3,9546,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9546,1,4,0)
 ;;=4^241.1
 ;;^UTILITY(U,$J,358.3,9546,1,5,0)
 ;;=5^Goiter, Nontox, Multinod
 ;;^UTILITY(U,$J,358.3,9546,2)
 ;;=^267790
 ;;^UTILITY(U,$J,358.3,9547,0)
 ;;=241.0^^67^663^50
 ;;^UTILITY(U,$J,358.3,9547,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9547,1,4,0)
 ;;=4^241.0
 ;;^UTILITY(U,$J,358.3,9547,1,5,0)
 ;;=5^Thyroid Nodule, Nontoxic
 ;;^UTILITY(U,$J,358.3,9547,2)
 ;;=^83865
 ;;^UTILITY(U,$J,358.3,9548,0)
 ;;=242.00^^67^663^15
 ;;^UTILITY(U,$J,358.3,9548,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9548,1,4,0)
 ;;=4^242.00
 ;;^UTILITY(U,$J,358.3,9548,1,5,0)
 ;;=5^Graves' Disease
